BioSpace News Archive

CNS Pharmaceuticals, Inc. announced that John Climaco, CEO of CNS Pharmaceuticals will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today preclinical results and filing of a patent covering the use of manipulated cord blood derived monocytes for prevention of suicidal ideations as well as inflammation of the brain.

Zepp Health Corp. (NYSE: ZEPP), and Rouumtech Co., Ltd., today announced the expansion of an agreement initially reached with predecessor Aspen Imaging Healthcare, to private label a customized Europa™ portable X-ray system, along with the company’s entire line of X-ray imaging products, for sales in China.

Swift Biosciences, pioneers in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) and SPT Labtech, providers of liquid handling solutions announce a collaboration to leverage Swift’s efficient NGS library preparation kits on SPT Labtech’s highly efficient mosquito® genomics and dragonfly® discovery.

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that it will host a Key Opinion Leader (KOL) Perspectives webinar on the Pathophysiology and Treatment of IgA Nephropathy in Clinical Practice on Wednesday, March 10, 2021 at 10:00am Eastern Time.

Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it has received a Health Canada license for the neXus® Ultrasonic Surgical System.

EchoNous, the leading developers of AI-driven, hand-carried ultrasound, today announced the addition of both continuous wave (CW) and pulsed wave (PW) Doppler capabilities to the Kosmos hardware platform, the company’s flagship offering.

This asset disposition reflects a continuum of Portage’s business strategy to focus on its pipeline of immuno-oncology platforms.

The OTCQB Venture Market, operated by OTC Markets Group Inc., is designed for developing and entrepreneurial companies in the U.S. and abroad.

LifeLabs is proud to support the Ontario government with the ongoing operation of in-person learning at child care centres, elementary and secondary schools across the province.